SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Chemo Pharma Laboratories informs about board meeting

15 May 2023 Evaluate
Chemo Pharma Laboratories has informed that the meeting of the Board of Directors of the Company is scheduled on 24/05/2023 to consider and approve the Audited Financial Results for the quarter and year ended March 31, 2023 along with the Auditor's Report thereon; To consider appointment of Sarda Soni & Associates as Internal Auditor of the Company for the financial year 2023-24; To consider appointment of Company Secretary and Compliance Officer of the Company.

The above information is a part of company’s filings submitted to BSE.

Starsource Multitrad Share Price

116.50 -6.10 (-4.98%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×